Bacterial diversity in Buruli ulcer skin lesions: Challenges in the clinical microbiome analysis of a skin disease
- PMID: 28750103
- PMCID: PMC5531519
- DOI: 10.1371/journal.pone.0181994
Bacterial diversity in Buruli ulcer skin lesions: Challenges in the clinical microbiome analysis of a skin disease
Abstract
Background: Buruli ulcer (BU) is an infectious disease caused by Mycobacterium ulcerans and considered the third most prevalent mycobacterial disease in humans. Secondary bacterial infections in open BU lesions are the main cause of pain, delayed healing and systemic illness, resulting in prolonged hospital stay. Thus, understanding the diversity of bacteria, termed the microbiome, in these open lesions is important for proper treatment. However, adequately studying the human microbiome in a clinical setting can prove difficult when investigating a neglected tropical skin disease due to its rarity and the setting.
Methodology/principal findings: Using 16S rRNA sequencing, we determined the microbial composition of 5 BU lesions, 3 non-BU lesions and 3 healthy skin samples. Although no significant differences in diversity were found between BU and non-BU lesions, the former were characterized by an increase of Bacteroidetes compared to the non-BU wounds and the BU lesions also contained significantly more obligate anaerobes. With this molecular-based study, we were also able to detect bacteria that were missed by culture-based methods in previous BU studies.
Conclusions/significance: Our study suggests that BU may lead to changes in the skin bacterial community within the lesions. However, in order to determine if such changes hold true across all BU cases and are either a cause or consequence of a specific wound environment, further microbiome studies are necessary. Such skin microbiome analysis requires large sample sizes and lesions from the same body site in many patients, both of which can be difficult for a rare disease. Our study proposes a pipeline for such studies and highlights several drawbacks that must be considered if microbiome analysis is to be utilized for neglected tropical diseases.
Conflict of interest statement
Figures




Similar articles
-
Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.BMC Microbiol. 2021 Jan 5;21(1):4. doi: 10.1186/s12866-020-02070-5. BMC Microbiol. 2021. PMID: 33402095 Free PMC article.
-
Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital.PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009862. doi: 10.1371/journal.pntd.0009862. eCollection 2021 Oct. PLoS Negl Trop Dis. 2021. PMID: 34644298 Free PMC article.
-
Genetic diversity of Staphylococcus aureus in Buruli ulcer.PLoS Negl Trop Dis. 2015 Feb 6;9(2):e0003421. doi: 10.1371/journal.pntd.0003421. eCollection 2015 Feb. PLoS Negl Trop Dis. 2015. PMID: 25658641 Free PMC article.
-
Buruli ulcer (Mycobacterium ulcerans infection).Trans R Soc Trop Med Hyg. 2008 Oct;102(10):969-78. doi: 10.1016/j.trstmh.2008.06.006. Epub 2008 Jul 26. Trans R Soc Trop Med Hyg. 2008. PMID: 18657836 Review.
-
Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.Dermatol Clin. 2011 Jan;29(1):1-8. doi: 10.1016/j.det.2010.09.006. Dermatol Clin. 2011. PMID: 21095521 Review.
Cited by
-
Investigation of skin microbiota reveals Mycobacterium ulcerans-Aspergillus sp. trans-kingdom communication.Sci Rep. 2021 Feb 12;11(1):3777. doi: 10.1038/s41598-021-83236-7. Sci Rep. 2021. PMID: 33580189 Free PMC article.
-
Characterization of skin surface and dermal microbiota in dogs with mast cell tumor.Sci Rep. 2020 Jul 28;10(1):12634. doi: 10.1038/s41598-020-69572-0. Sci Rep. 2020. PMID: 32724217 Free PMC article.
-
Mycobacterium ulcerans-Bordetella trematum chronic tropical cutaneous ulcer: A four-case series, Côte d'Ivoire.PLoS Negl Trop Dis. 2023 Dec 7;17(12):e0011413. doi: 10.1371/journal.pntd.0011413. eCollection 2023 Dec. PLoS Negl Trop Dis. 2023. PMID: 38060465 Free PMC article.
-
Cutaneous tuberculosis-ambiguous transmission, bacterial diversity with biofilm formation in humoral abnormality: case report illustration.Front Public Health. 2023 Apr 21;11:1091373. doi: 10.3389/fpubh.2023.1091373. eCollection 2023. Front Public Health. 2023. PMID: 37213612 Free PMC article.
-
PPE Barcoding Identifies Biclonal Mycobacterium ulcerans Buruli Ulcer, Côte d'Ivoire.Microbiol Spectr. 2023 Jun 15;11(3):e0034223. doi: 10.1128/spectrum.00342-23. Epub 2023 May 24. Microbiol Spectr. 2023. PMID: 37222600 Free PMC article.
References
-
- Walsh DS, Portaels F, Meyers WM. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection. Dermatol Clin. 2011;29: 1–8. doi: 10.1016/j.det.2010.09.006 - DOI - PubMed
-
- Organisation mondiale de la Santé. Traitement de l’infection à mycobacterium ulcerans (ulcère de Buruli): recommandations à l’intention des agents de santé. Organisation mondiale de la Santé; 2012;
-
- Kibadi K, Boelaert M, Fraga AG, Kayinua M, Longatto-Filho A, Minuku J-B, et al. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). PLoS Negl Trop Dis. 2010;4: e736 doi: 10.1371/journal.pntd.0000736 - DOI - PMC - PubMed
-
- Barogui YT, Klis S, Bankolé HS, Sopoh GE, Mamo S, Baba-Moussa L, et al. Towards Rational Use of Antibiotics for Suspected Secondary Infections in Buruli Ulcer Patients. Small PLC, editor. PLoS Negl Trop Dis. Public Library of Science; 2013;7: e2010 doi: 10.1371/journal.pntd.0002010 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources